CClinicalTrials.gg
CompletedNCT06962566Updated May 13, 2025

Effects of Different Timing of Brisk Walking on Human Behaviours

An interventional study of Morning exercise and Evening exercise in Physical Activity, Energy Intake and Sedentary Behavior, sponsored by National Taiwan Normal University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-13.

Sponsored by National Taiwan Normal University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jul 2024, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

The purpose of this project is to investigate the effects of exercise at different times of day on 72-hour eating behaviour, physical activity and sedentary behaviour in physically inactive adults.

Read the detailed description

Eligibility and Consent Confirmation Prior to the one-week preliminary test, participants underwent eligibility screening, including measurements of height, weight, and body composition. After the researchers provided a detailed explanation of the experimental procedures, participants decided whether to participate in the study. Eligible participants then completed a 10-minute treadmill walking session (6.4 km/h for males and 6.0 km/h for females) to familiarize themselves with the exercise intensity. Subsequently, the researchers explained the use of pedometers and distributed dietary record forms.

During a one-week preliminary test, participants were instructed to record their physical activity levels measured in steps, sleep duration including wake-up and sleep times, and dietary behaviours through photographs taken (2 weekdays and 1 weekend day) over a period of 7 consecutive days. Participants were allowed to take part in this study, once they met the inclusion criteria: 1) an average daily step count of less than 7,500 over the course of the week and 2) a wake-up time no later than 11:00 AM).

Exercise intervention During the main trials, two main trials, separated by at least one week, were conducted - exercise in the morning (08:00 to 11:00 AM) or exercise in the evening (18:00 to 21:00 PM).

In both trials, participants completed the first Visual Analogue Scale (VAS) for subjective appetite upon waking, wore a pedometer and an accelerometer, and recorded energy intake and physical activity over a 3-day period (the day before exercise intervention, the exercise day and the day after exercise intervention). Upon arrival at the laboratory, participants completed the second VAS, followed by a 15-minute waiting period before commencing the exercise. Participants then performed a 45-minute treadmill brisk walk (6.4 km/h for males, 6.0 km/h for females), followed by a 15-minute rest period, after which they completed the third VAS.

Heart rate and Rating of Perceived Exertion (RPE) were measured every 15 minutes during exercise. Energy balance (e.g., energy intake and spontaneous physical activity) was assessed using a food diary, Actigraph wGT3x-BT accelerometer (Actigraph Co., Ltd., Pensacola, FL, USA), and pedometer (Realalt, Goldhat Ltd., UK), which were worn starting from the night two days before the experiment and removed after waking up two days post-experiment.

02

Conditions studied

  • Physical Activity
  • Energy Intake
  • Sedentary Behavior

Keywords

  • Timing of exercise
  • Morning exercise
  • Evening exercise
  • Behavioural compensation
03

In context

Lead sponsor

National Taiwan Normal University is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged between 20 and 50 years, with a BMI ranging from 19 to 27 kg/m².
  • Classified as having "low" physical activity levels (750 Metabolic Equivalents / week) according to the International Physical Activity Questionnaire (IPAQ).
  • Engaged in moderate-intensity exercise for no more than 3 days per week and less than 30 minutes per session in the 3 months preceding the study.
  • Maintained a stable body weight (± 3 kg) during the 3 months prior to the main experiment.
  • Not taking any medications, supplements, or vitamins that might affect food intake, appetite, physical activity, weight loss, or metabolism.
  • Free from cardiovascular and metabolic diseases.
  • Not pregnant or planning to become pregnant.
  • Not currently on a diet or undergoing any specific dietary interventions (e.g., intermittent fasting, ketogenic diet).
  • No injuries or surgical wounds preventing physical activity.
  • Regular sleep patterns, averaging 7-9 hours per night, with no shift work.
  • No habits of heavy alcohol consumption or smoking.

Exclusion criteria

Exclusion Criteria:

  • Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia.
  • Taking medications that may influence lipid or carbohydrate metabolism or immune system function.
  • Unable to take part in exercise for any reason (e.g., injury or disability) or a positive response to any questions on the Physical Activity Readiness questionnaire (PAR-Q).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Morning exercise

    Brisk walking in the morning

    Behavioral: Morning exercise

  • Experimental
    Evening exercise

    Brisk walking in the evening

    Behavioral: Evening exercise

Interventions

  • BehavioralMorning exercise

    Participants performed a 45-minute treadmill brisk walking in the morning between 08:00 to 11:00 AM.

  • BehavioralEvening exercise

    Participants performed a 45-minute treadmill brisk walking in the evening between 18:00 to 21:00 PM.

06

What researchers measure

Primary outcomes

  1. Physical activity

    Changes in physical activity intensity (minutes and percentage during 72 hours) and levels (minutes and percentage during 72 hours) between trials

    Time frame: 72 hours (24 hours before exercise day, exercise day and 24 hours after exercise day)

  2. Energy intake

    Changes in total and macronutrient energy intake between trials

    Time frame: 72 hours (24 hours before exercise day, exercise day and 24 hours after exercise day)

  3. Sedentary behaviour

    Changes in sedentary behaviour (minutes and percentage during 72 hours) between trials

    Time frame: 72 hours (24 hours before exercise day, exercise day and 24 hours after exercise day)

Secondary outcomes

  1. Heart Rate

    Changes in heart rate (bpm) during exercise between trials

    Time frame: During 45 minutes exercise

  2. Rating of Perceived Exertion (RPE)

    Changes in Rating of Perceived Exertion using Borg 6-20 scale (6 indicates no exertion and 20 indicates maximal effort) during exercise between trials

    Time frame: During 45 minutes exercise

  3. Visual analogue scale (VAS)

    Changes in Visual analogue scale (appetite) using 0-100 mm scale (0 indicates not at all and 100 indicates very much) during exercise between trials

    Time frame: Baseline upon wake up in the morning,15 minutes before exercise and 15 minutes after exercise

07

Study locations

1 site
  • National Taiwan Normal University
    Taipei, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06962566
Lead sponsor
National Taiwan Normal University
Responsible party
Yung-Chih Chen (Principal Investigator, National Taiwan Normal University) — Principal investigator
First posted
May 8, 2025
Start date
Jul 23, 2024
Primary completion
Mar 24, 2025
Completion
Mar 24, 2025
Last update
May 13, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion